{"nct_id":"NCT02301975","title":"An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma","status":"COMPLETED","status_verified_date":"2018-08","start_date":"2015-03-01","start_date_type":null,"primary_completion_date":"2016-11-01","primary_completion_date_type":"ACTUAL","completion_date":"2016-11-25","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}